Are Prophylactic and Therapeutic Target Concentrations Different?: the Case of Lopinavir-Ritonavir or Lamivudine Administered to Infants for Prevention of Mother-to-Child HIV-1 Tra...

Por Foissac, Frantz, Blume, Jörn, Tréluyer, Jean-Marc, Tylleskär, Thorkild, Kankasa, Chipepo, Meda, Nicolas, Tumwine, James K., Singata-Madliki, Mandisa, Harper, Kim, Illamola, Silvia M., Bouazza, Naïm, Nagot, Nicolas, Van de Perre, Philippe, Blanche, Stéphane, Hirt, Déborah
Publicado no Antimicrob Agents Chemother (2017)